Sarepta Therapeutics (SRPT) Profit After Tax Growth (5y) (2015 - 2026)
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Profit After Tax Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.02% |
| Mar 31, 2026 | 31.81% |
| Dec 31, 2025 | -16.84% |
| Sep 30, 2025 | 23.77% |
| Jun 30, 2025 | 27.23% |
| Mar 31, 2025 | -91.25% |
| Dec 31, 2024 | 21.75% |
| Sep 30, 2024 | 17.78% |
| Jun 30, 2024 | 15.14% |
| Mar 31, 2024 | 19.84% |
| Dec 31, 2023 | 18.37% |
| Sep 30, 2023 | 11.73% |
| Jun 30, 2023 | 26.19% |
| Mar 31, 2023 | -70.98% |
| Dec 31, 2022 | -34.61% |
| Sep 30, 2022 | -40.19% |
| Jun 30, 2022 | -29.71% |
| Mar 31, 2022 | -26.58% |
| Dec 31, 2021 | -6.64% |
| Sep 30, 2021 | 3.22% |